Philippe Gautret ,Jean-Christophe Lagier ,Philippe Parola ,Van Thuan Hoang ,Line Meddeb ,Morgane Mailhe ,Barbara Doudier ,Johan Courjon ,Val ́erie Giordanengo ,Vera Esteves Vieira ,Herv ́e Tissot Dupont ,St ́ephane Honor ́e ,Philippe Colson ,Eric Chabri, Bernard La Scola ,Jean-Marc Rolain ,Philippe Brouqui ,Didier Raoult 
https://doi.org/10.1016/j.ijantimicag.2020.105949

University of Michigan - Ann Arbor

- Appeared on 3/16/2020 on medRxiv.
- The manuscript was also sent to International Journal of Antimicrobial Agents on 3/16/2020.
- The manuscript was accepted by the journal on 3/17/2020.
- The paper was published by the journal on 3/20/2020

"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial" (Gautret et al.) as an example of inappropriate findings and results

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

New York Times: 
Artile title: "He Was a Science Star. Then He Promoted a Questionable Cure for Covid-19."
Publied: 5/12/2020
URL: https://www.nytimes.com/2020/05/12/magazine/didier-raoult-hydroxychloroquine.html


New York Times article on Dr. Didier Raoult, a microbiologist, who is one of the main investigators of the study on Hydroxychloroquine (Gautret et al.)

Learn Before

Related